Business Development & Licensing Course For Pharma & Biotech
With Dr Carlos Velez
Course Details
For many pharma companies, the most significant source of new products lies in Business Development (BD).
Often, the BD function falls short due to a lack of strategic alignment and a failure to coordinate efforts across the organisation.
To optimise successful transactions and partnerships, companies need a structured BD&L process, and all contributors need to understand the whole process.
This course offers a unique opportunity to speed up your learning curve by giving you a comprehensive overview of the licensing process in the context of business development in the pharma-biotech world.
Not only will you have the opportunity to consult directly with an experienced pharma licensing expert, but you’ll also engage in meaningful discussions and share experiences with international peers, making this a truly unique learning experience.
This two-day Business Development and Licensing course was an incredibly enriching experience. Dr Carlos Velez is an excellent teacher who explains complex topics with both clarity and depth. The course offers strong value: the content, tools, and references are thoughtfully selected and highly practical. What makes it stand out is Carlos’s ability to share not just academic knowledge, but practical insights drawn from years of real-world experience. His perspective adds meaning and relevance that go beyond standard materials. A truly worthwhile learning experience.
Inventprise
Olivier Brun, Sr Director Global Access Strategies & General Manager Switzerland - Switzerland - June 2025
The role of the BD&L function and partnering models for corporate growth.
Key success factors and tips for the planning and execution of the out-licensing process.
Key success factors and tips for the planning and execution of the in-licensing process.
What you need to know about patents and intellectual property.
Overview of forecasting and valuation tools, methods and approaches.
Introduction to term sheets, negotiation, closing the deal and managing the alliance.
This course offers a broad introduction to all key aspects of the BD field. Highly recommended for anyone looking to develop their career in this area.
Reig Jofré
Xiaoyi Zhu, Business Development Manager (In-licensing) - Spain - June 2025
Day 1
| Welcome & Audience Expectations (~30 min) |
| Introduction to Business Development in Pharma/Biotech (~1 h) |
|
| Out-Licensing: Planning and Execution (~1 h) |
|
| Lunch Break |
| In-Licensing: Planning and Execution (~1 h) |
|
| Patents and Intellectual Property: Goal, Definition & Process (~1 h) |
|
| Valuation of Drug Candidates – Part I: Forecasting the Opportunity (~1 h 30 min) |
|
Day 2
| Day One Questions and Comments (~30 min) |
| Valuation of Drug Candidates – Part II: Tools, Methods & Approaches (~3 h) |
|
| Lunch Break |
| Term Sheets and Contracts (~1 h 30 min) |
|
| Negotiation, Closing, Alliance Management (~45 min) |
|
| Group Work on a Case Study: Term Sheets, Valuation and Negotiation (~1 h 30 min) |
| Participants will be divided into two teams, and work on a pharma/biotech case study to gain practice with term sheets, valuation and preparing a negotiation. |
| Q&A and Closing (~15 min) |
Dr Carlos Velez is the Founder and Managing Partner of Lacerta Bio, an international consultancy specialising in both in- and out-licensing of prescription and non-prescription product candidates and commercial products, across multiple therapeutic areas and markets.
Prior to that, Carlos built a 10+ years career in senior Business Development roles at Penwest Pharmaceuticals, Lantic Therapeutics Forest Labs, and Genencor (now Danisco).
Carlos has trained and consulted with life science executives around the world on in- and out-licensing. Participants applaud him for his excellent didactic approach and his ability to draw from his vast experience in BD & Licensing.
Dr Carlos Velez is an incredible teacher who explains complex topics with clarity and deep expertise. This course delivers unmatched value: the content, tools, and sources are worth far more than the price. But what makes it truly exceptional is how Carlos shares not only knowledge, but the insights of a lifelong career in Business Development, straight from the heart. These pearls of wisdom can't be found in textbooks and offer the kind of learning that shapes careers. Thank you for an outstanding experience.
CEE Services
David Marmaros, CEO - Hungary - June 2025
The Business Development & Licensing Course For Pharma & Biotech is an ideal introductory course for two categories of executives:
Mid- to senior-level executives in small pharma and biotech companies with limited formal training in business development & licensing but whose role increasingly involves licensing activities.
Junior- to mid-level managers contributing to the BD&L process in the headquarters of midsize and big pharma companies (e.g. technology assessment, business intelligence…) who need a better understanding of the complete licensing process in the context of business development.
Managers in local marketing organisations with responsibility for business development & licensing in national markets will also benefit but they should be aware that the course content is geared towards international licensing BD responsibilities.
Executives working in generics companies should be aware that the content of this course concentrates on licensing deals involving branded pharmaceuticals.
If you are a consultant, please contact Annelies Swaan, who will check with the faculty whether you can attend.
Would you like to receive a list of anonymised participant profiles from previous sessions?
Email Annelies Swaan
UPCOMING DATES & FORMATS - FEES
25-26 September 2025
Brussels
Early bird € 2 970
(until 08/08/2025)
(Full fee € 3 370)
4-5 December 2025
Live online (CET timing)
Early bird € 2 670
(until 31/10/2025)
(Full fee € 2 870)
9-10 December 2025
Live online (EST timing)
Early bird € 2 670
(until 07/11/2025)
(Full fee € 2 870)
TIMING & LOCATION
Live Online (CET): Zoom sessions between 9 AM and 5 PM CET (Brussels, Amsterdam, Paris time).
Live Online (EST): Zoom sessions between 8 AM and 4 PM EST (Eastern Standard Time).
Face-to-Face: Held at the Crowne Plaza Brussels Airport (Da Vincilaan 4, 1831 Brussels), between 9 AM and 5 PM CET. Preferential hotel rates available for participants.
All practical details will be shared upon registration. For any questions, please contact Margherita Mutto or call +32 472 03 11 38 .
SPECIAL OFFER FOR BIOTECH EXECUTIVES
Executives from biotech start-ups (companies that do not have products on the market yet) and academia can apply for a € 400 discount. Please email Annelies Swaan, Director Business Operations, for more details.
GROUP DISCOUNTS
Team discounts can be offered to 2 or more delegates from the same company.
Email Annelies Swaan, Director Business Operations, for more details.
HOW TO REGISTER
Click the green “Register” button on your preferred course session.
The registration wizard will guide you through the process.Alternatively, download the offline registration form and send the completed form to Annelies Swaan.
PAYMENT OPTIONS
Credit Card: You’ll receive a secure payment link with your invoice (no immediate payment required).
Bank Transfer: Details provided with your invoice.
For help with registration, email Annelies Swaan or contact her by phone at +32 486 98 52 49.
INCLUDED IN THE REGISTRATION FEE
For live online courses:
Access to a highly interactive, small-group online course (max 20 participants)
Course materials in both digital and hard copy format
Certificate of attendance signed by the experts and CELforPharma
For face-to-face courses:
Access to a highly interactive, small-group course (max 20 participants)
Course materials in both digital and hard copy format
Certificate of attendance signed by the experts and CELforPharma
Opportunities for networking and informal discussions during coffee/tea breaks and lunch
A group dinner in a nearby restaurant on the evening of day 1
VAT INFORMATION
Prices exclude VAT. VAT application depends on course format and your location:
Face-to-Face in Belgium: 21% Belgian VAT applies
Live online courses & self-study programme: The applicable VAT depends on your invoicing address. Contact your local VAT office for refund procedures where applicable.
TRANSFER & CANCELLATION POLICY
Flexible Transfer
If a registrant is unable to attend the scheduled course, they can avoid any cancellation charges by providing a suitable replacement participant.
Alternatively, the registrant may transfer once, on a 'space-available' basis and at no extra cost, to another course of the same value held within one year of the original course date, provided this is done at least three weeks prior to the event.
Registration Cancellation
Less than 14 days prior to the course date: The registrant is liable to pay the full invoiced registration fee.
Between 15 and 30 days prior to the course date: The registrant is liable to pay 50% of the invoiced registration fee.
More than 30 days prior to the course date: The registrant is liable to pay a cancellation fee of € 450 per registrant.
If a registrant postpones their participation to a future course and subsequently cancels again, no refund will be issued for the registration fees.
The average Recommendation Score from participants of the last session was
9,0/10!
Testimonials from past participants:
Dr Carlos Velez is an incredible teacher who explains complex topics with clarity and deep expertise. This course delivers unmatched value: the content, tools, and sources are worth far more than the price. But what makes it truly exceptional is how Carlos shares not only knowledge, but the insights of a lifelong career in Business Development, straight from the heart. These pearls of wisdom can't be found in textbooks and offer the kind of learning that shapes careers. Thank you for an outstanding experience.
CEE Services
David Marmaros, CEO - Hungary - June 2025
Attending the 2-day Business Development and Licensing course was an incredibly enriching experience. The sessions were thoughtfully structured, and the quality of discussions was exceptional throughout. The facilitators created an engaging environment that encouraged active participation and real-world application.
3D Matrix Europe
Sharanya Sankar, R&D and Business Development Manager - France - June 2025
This course offers a broad introduction to all key aspects of the BD field. Highly recommended for anyone looking to develop their career in this area.
Reig Jofré
Xiaoyi Zhu, Business Development Manager (In-licensing) - Spain - June 2025
This two-day Business Development and Licensing course was an incredibly enriching experience. Dr Carlos Velez is an excellent teacher who explains complex topics with both clarity and depth. The course offers strong value: the content, tools, and references are thoughtfully selected and highly practical. What makes it stand out is Carlos’s ability to share not just academic knowledge, but practical insights drawn from years of real-world experience. His perspective adds meaning and relevance that go beyond standard materials. A truly worthwhile learning experience.
Inventprise
Olivier Brun, Sr Director Global Access Strategies & General Manager Switzerland - Switzerland - June 2025
The course covered a broad range of topics within the Business Development and Licensing world, making it highly valuable. Carlos is an eloquent speaker, and CELforPharma is helpful and supportive.
Tecnimede
Alexandre Sousa Coelho, Junior In-licensing and Business Development Manager - Portugal - March 2025
An outstanding course with excellent organisation and a very experienced teacher. Well worth attending to gain valuable insights into many aspects of Business Development & Licensing. Highly recommended, regardless of your level of experience.
Syva
Alfonso Martín-Fontecha, Business Development Technical Manager - Spain - March 2025
A great, hands-on Business Development course.
Gergely Vertes, Biotech Launch Lead - Rare Disease Expert - Belgium - March 2025
Very informative course for professionals entering the BD market. The trainer is obviously vastly experienced in this sector and managed to transfer a lot of knowledge to the participants.
Viatris
Zafeirios Anagnostopoulos, Senior Medical Manager Business Development - Europe - December 2024
It was a great course with good interaction! I have learned tools, specific terms, and some financial aspects. My company is more oriented on CPALs, ..., active ingredients, and not so much pills anymore, so I am a bit far from pre-clinicals and phases, but that was in the name of the course and still good to explore. Thank you!
Expanscience Laboratories
Sacha Marsollier, Business Development Project Manager - France - September 2024
Carlos Velez is a great speaker and very didactical!
Exeltis
Julia Redondo, Open Innovation Manager - Spain - June 2024
This course gave a complete overview of all BD aspects. Carlos' own experience, examples and practical tips really added to this learning experience and the tools & processes shared (e.g. pitch deck, follow up, etc.) were also valuable. Thank you very much for two engaging and insightful days!
Zealand Pharma
Dino Bertani, Vice President, Head of Alliance Management - Denmark - March 2024
Excellent course covering the fundamentals of in- and out-licensing for pharma and biotech. Highly recommended to anyone involved with licensing in biotech.
Debiopharm
Blaise Calpe, Evaluation Manager Oncology - Switzerland - March 2024
Very valuable course with great content, good speaker and great organisation.
Neuvasq
Isabel Vogel, Senior Scientist/Alliance Manager - Belgium - March 2024
I enjoyed this dynamic and comprehensive introduction to BD&L for Pharma and Biotech. I strongly recommend this course for anyone who is looking for an overview of the in- and out-licensing process.
Boehringer Ingelheim
Hervé Poulet, Strategic Partnerships Senior Director - France - November 2023
Carlos is a great speaker, sharing knowledge & experience in a dynamic and pleasant manner, even in a live online format.
Valneva
Henri Pierre, Global Brand Director - France - November 2023
The "Business Development & Licensing Course For Pharma & Biotech" has been an excellent opportunity for me to benchmark my technical skills with other relevant professionals, to get new insights on the topic and, at a glance, to improve the way I do my job and the value I can bring to the company.
Molteni Farma
Rodolfo Perriccioli, Business Development & Alliance Management - Italy - November 2023
Really interesting course with a valuable expert. The organisation by the CELforPharma team was very nice.
Horus Pharma
Camille Guerin, R&D Director & Interim Qualified Person - France - September 2023
For pharmaceutical executives who don't work directly in BD&L, this is probably the best course to learn the basics and much more in this field.
Daiichi Sankyo
Dan Ionescu, VP, Head of Value and Access Specialty Medicines EU - Germany - September 2023
Valuable course for BD&L professionals and people who want to understand this perspective of the industry.
Alkaloid
Viktorija Pavlovikj, Out Licensing Specialist - North Macedonia - September 2023
People attending this course are typically also interested in:
Course Details
Dates & Locations
Special offer for biotech start-ups & academia: Apply for a € 400 discount. Contact Annelies Swaan for more details.
Upcoming Session
25-26 September 2025, Brussels
Early bird € 2 970
(until 08/08/2025)
(Full fee € 3 370)
Prices are excl. VAT
For many pharma companies, the most significant source of new products lies in Business Development (BD).
Often, the BD function falls short due to a lack of strategic alignment and a failure to coordinate efforts across the organisation.
To optimise successful transactions and partnerships, companies need a structured BD&L process, and all contributors need to understand the whole process.
This course offers a unique opportunity to speed up your learning curve by giving you a comprehensive overview of the licensing process in the context of business development in the pharma-biotech world.
Not only will you have the opportunity to consult directly with an experienced pharma licensing expert, but you’ll also engage in meaningful discussions and share experiences with international peers, making this a truly unique learning experience.
This two-day Business Development and Licensing course was an incredibly enriching experience. Dr Carlos Velez is an excellent teacher who explains complex topics with both clarity and depth. The course offers strong value: the content, tools, and references are thoughtfully selected and highly practical. What makes it stand out is Carlos’s ability to share not just academic knowledge, but practical insights drawn from years of real-world experience. His perspective adds meaning and relevance that go beyond standard materials. A truly worthwhile learning experience.
Inventprise
Olivier Brun, Sr Director Global Access Strategies & General Manager Switzerland - Switzerland - June 2025
The role of the BD&L function and partnering models for corporate growth.
Key success factors and tips for the planning and execution of the out-licensing process.
Key success factors and tips for the planning and execution of the in-licensing process.
What you need to know about patents and intellectual property.
Overview of forecasting and valuation tools, methods and approaches.
Introduction to term sheets, negotiation, closing the deal and managing the alliance.
This course offers a broad introduction to all key aspects of the BD field. Highly recommended for anyone looking to develop their career in this area.
Reig Jofré
Xiaoyi Zhu, Business Development Manager (In-licensing) - Spain - June 2025
Day 1
| Welcome & Audience Expectations (~30 min) |
| Introduction to Business Development in Pharma/Biotech (~1 h) |
|
| Out-Licensing: Planning and Execution (~1 h) |
|
| Lunch Break |
| In-Licensing: Planning and Execution (~1 h) |
|
| Patents and Intellectual Property: Goal, Definition & Process (~1 h) |
|
| Valuation of Drug Candidates – Part I: Forecasting the Opportunity (~1 h 30 min) |
|
Day 2
| Day One Questions and Comments (~30 min) |
| Valuation of Drug Candidates – Part II: Tools, Methods & Approaches (~3 h) |
|
| Lunch Break |
| Term Sheets and Contracts (~1 h 30 min) |
|
| Negotiation, Closing, Alliance Management (~45 min) |
|
| Group Work on a Case Study: Term Sheets, Valuation and Negotiation (~1 h 30 min) |
| Participants will be divided into two teams, and work on a pharma/biotech case study to gain practice with term sheets, valuation and preparing a negotiation. |
| Q&A and Closing (~15 min) |
Dr Carlos Velez is the Founder and Managing Partner of Lacerta Bio, an international consultancy specialising in both in- and out-licensing of prescription and non-prescription product candidates and commercial products, across multiple therapeutic areas and markets.
Prior to that, Carlos built a 10+ years career in senior Business Development roles at Penwest Pharmaceuticals, Lantic Therapeutics Forest Labs, and Genencor (now Danisco).
Carlos has trained and consulted with life science executives around the world on in- and out-licensing. Participants applaud him for his excellent didactic approach and his ability to draw from his vast experience in BD & Licensing.
Dr Carlos Velez is an incredible teacher who explains complex topics with clarity and deep expertise. This course delivers unmatched value: the content, tools, and sources are worth far more than the price. But what makes it truly exceptional is how Carlos shares not only knowledge, but the insights of a lifelong career in Business Development, straight from the heart. These pearls of wisdom can't be found in textbooks and offer the kind of learning that shapes careers. Thank you for an outstanding experience.
CEE Services
David Marmaros, CEO - Hungary - June 2025
The Business Development & Licensing Course For Pharma & Biotech is an ideal introductory course for two categories of executives:
Mid- to senior-level executives in small pharma and biotech companies with limited formal training in business development & licensing but whose role increasingly involves licensing activities.
Junior- to mid-level managers contributing to the BD&L process in the headquarters of midsize and big pharma companies (e.g. technology assessment, business intelligence…) who need a better understanding of the complete licensing process in the context of business development.
Managers in local marketing organisations with responsibility for business development & licensing in national markets will also benefit but they should be aware that the course content is geared towards international licensing BD responsibilities.
Executives working in generics companies should be aware that the content of this course concentrates on licensing deals involving branded pharmaceuticals.
If you are a consultant, please contact Annelies Swaan, who will check with the faculty whether you can attend.
Would you like to receive a list of anonymised participant profiles from previous sessions?
Email Annelies Swaan
UPCOMING DATES & FORMATS - FEES
25-26 September 2025
Brussels
Early bird € 2 970
(until 08/08/2025)
(Full fee € 3 370)
4-5 December 2025
Live online (CET timing)
Early bird € 2 670
(until 31/10/2025)
(Full fee € 2 870)
9-10 December 2025
Live online (EST timing)
Early bird € 2 670
(until 07/11/2025)
(Full fee € 2 870)
TIMING & LOCATION
Live Online (CET): Zoom sessions between 9 AM and 5 PM CET (Brussels, Amsterdam, Paris time).
Live Online (EST): Zoom sessions between 8 AM and 4 PM EST (Eastern Standard Time).
Face-to-Face: Held at the Crowne Plaza Brussels Airport (Da Vincilaan 4, 1831 Brussels), between 9 AM and 5 PM CET. Preferential hotel rates available for participants.
All practical details will be shared upon registration. For any questions, please contact Margherita Mutto or call +32 472 03 11 38 .
SPECIAL OFFER FOR BIOTECH EXECUTIVES
Executives from biotech start-ups (companies that do not have products on the market yet) and academia can apply for a € 400 discount. Please email Annelies Swaan, Director Business Operations, for more details.
GROUP DISCOUNTS
Team discounts can be offered to 2 or more delegates from the same company.
Email Annelies Swaan, Director Business Operations, for more details.
HOW TO REGISTER
Click the green “Register” button on your preferred course session.
The registration wizard will guide you through the process.Alternatively, download the offline registration form and send the completed form to Annelies Swaan.
PAYMENT OPTIONS
Credit Card: You’ll receive a secure payment link with your invoice (no immediate payment required).
Bank Transfer: Details provided with your invoice.
For help with registration, email Annelies Swaan or contact her by phone at +32 486 98 52 49.
INCLUDED IN THE REGISTRATION FEE
For live online courses:
Access to a highly interactive, small-group online course (max 20 participants)
Course materials in both digital and hard copy format
Certificate of attendance signed by the experts and CELforPharma
For face-to-face courses:
Access to a highly interactive, small-group course (max 20 participants)
Course materials in both digital and hard copy format
Certificate of attendance signed by the experts and CELforPharma
Opportunities for networking and informal discussions during coffee/tea breaks and lunch
A group dinner in a nearby restaurant on the evening of day 1
VAT INFORMATION
Prices exclude VAT. VAT application depends on course format and your location:
Face-to-Face in Belgium: 21% Belgian VAT applies
Live online courses & self-study programme: The applicable VAT depends on your invoicing address. Contact your local VAT office for refund procedures where applicable.
TRANSFER & CANCELLATION POLICY
Flexible Transfer
If a registrant is unable to attend the scheduled course, they can avoid any cancellation charges by providing a suitable replacement participant.
Alternatively, the registrant may transfer once, on a 'space-available' basis and at no extra cost, to another course of the same value held within one year of the original course date, provided this is done at least three weeks prior to the event.
Registration Cancellation
Less than 14 days prior to the course date: The registrant is liable to pay the full invoiced registration fee.
Between 15 and 30 days prior to the course date: The registrant is liable to pay 50% of the invoiced registration fee.
More than 30 days prior to the course date: The registrant is liable to pay a cancellation fee of € 450 per registrant.
If a registrant postpones their participation to a future course and subsequently cancels again, no refund will be issued for the registration fees.
The average Recommendation Score from participants of the last session was
9,0/10!
Testimonials from past participants:
Dr Carlos Velez is an incredible teacher who explains complex topics with clarity and deep expertise. This course delivers unmatched value: the content, tools, and sources are worth far more than the price. But what makes it truly exceptional is how Carlos shares not only knowledge, but the insights of a lifelong career in Business Development, straight from the heart. These pearls of wisdom can't be found in textbooks and offer the kind of learning that shapes careers. Thank you for an outstanding experience.
CEE Services
David Marmaros, CEO - Hungary - June 2025
Attending the 2-day Business Development and Licensing course was an incredibly enriching experience. The sessions were thoughtfully structured, and the quality of discussions was exceptional throughout. The facilitators created an engaging environment that encouraged active participation and real-world application.
3D Matrix Europe
Sharanya Sankar, R&D and Business Development Manager - France - June 2025
This course offers a broad introduction to all key aspects of the BD field. Highly recommended for anyone looking to develop their career in this area.
Reig Jofré
Xiaoyi Zhu, Business Development Manager (In-licensing) - Spain - June 2025
This two-day Business Development and Licensing course was an incredibly enriching experience. Dr Carlos Velez is an excellent teacher who explains complex topics with both clarity and depth. The course offers strong value: the content, tools, and references are thoughtfully selected and highly practical. What makes it stand out is Carlos’s ability to share not just academic knowledge, but practical insights drawn from years of real-world experience. His perspective adds meaning and relevance that go beyond standard materials. A truly worthwhile learning experience.
Inventprise
Olivier Brun, Sr Director Global Access Strategies & General Manager Switzerland - Switzerland - June 2025
The course covered a broad range of topics within the Business Development and Licensing world, making it highly valuable. Carlos is an eloquent speaker, and CELforPharma is helpful and supportive.
Tecnimede
Alexandre Sousa Coelho, Junior In-licensing and Business Development Manager - Portugal - March 2025
An outstanding course with excellent organisation and a very experienced teacher. Well worth attending to gain valuable insights into many aspects of Business Development & Licensing. Highly recommended, regardless of your level of experience.
Syva
Alfonso Martín-Fontecha, Business Development Technical Manager - Spain - March 2025
A great, hands-on Business Development course.
Gergely Vertes, Biotech Launch Lead - Rare Disease Expert - Belgium - March 2025
Very informative course for professionals entering the BD market. The trainer is obviously vastly experienced in this sector and managed to transfer a lot of knowledge to the participants.
Viatris
Zafeirios Anagnostopoulos, Senior Medical Manager Business Development - Europe - December 2024
It was a great course with good interaction! I have learned tools, specific terms, and some financial aspects. My company is more oriented on CPALs, ..., active ingredients, and not so much pills anymore, so I am a bit far from pre-clinicals and phases, but that was in the name of the course and still good to explore. Thank you!
Expanscience Laboratories
Sacha Marsollier, Business Development Project Manager - France - September 2024
Carlos Velez is a great speaker and very didactical!
Exeltis
Julia Redondo, Open Innovation Manager - Spain - June 2024
This course gave a complete overview of all BD aspects. Carlos' own experience, examples and practical tips really added to this learning experience and the tools & processes shared (e.g. pitch deck, follow up, etc.) were also valuable. Thank you very much for two engaging and insightful days!
Zealand Pharma
Dino Bertani, Vice President, Head of Alliance Management - Denmark - March 2024
Excellent course covering the fundamentals of in- and out-licensing for pharma and biotech. Highly recommended to anyone involved with licensing in biotech.
Debiopharm
Blaise Calpe, Evaluation Manager Oncology - Switzerland - March 2024
Very valuable course with great content, good speaker and great organisation.
Neuvasq
Isabel Vogel, Senior Scientist/Alliance Manager - Belgium - March 2024
I enjoyed this dynamic and comprehensive introduction to BD&L for Pharma and Biotech. I strongly recommend this course for anyone who is looking for an overview of the in- and out-licensing process.
Boehringer Ingelheim
Hervé Poulet, Strategic Partnerships Senior Director - France - November 2023
Carlos is a great speaker, sharing knowledge & experience in a dynamic and pleasant manner, even in a live online format.
Valneva
Henri Pierre, Global Brand Director - France - November 2023
The "Business Development & Licensing Course For Pharma & Biotech" has been an excellent opportunity for me to benchmark my technical skills with other relevant professionals, to get new insights on the topic and, at a glance, to improve the way I do my job and the value I can bring to the company.
Molteni Farma
Rodolfo Perriccioli, Business Development & Alliance Management - Italy - November 2023
Really interesting course with a valuable expert. The organisation by the CELforPharma team was very nice.
Horus Pharma
Camille Guerin, R&D Director & Interim Qualified Person - France - September 2023
For pharmaceutical executives who don't work directly in BD&L, this is probably the best course to learn the basics and much more in this field.
Daiichi Sankyo
Dan Ionescu, VP, Head of Value and Access Specialty Medicines EU - Germany - September 2023
Valuable course for BD&L professionals and people who want to understand this perspective of the industry.
Alkaloid
Viktorija Pavlovikj, Out Licensing Specialist - North Macedonia - September 2023
People attending this course are typically also interested in: